News

Administration to phase out NIH support of HIV clinical guidelines
The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
FDA approves twice-a-year injection for HIV prevention
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
CNN16d
FDA approves twice-a-year injection for HIV prevention - CNN
Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.
NBC New York16d
FDA approves powerful HIV prevention drug: What to know
Despite fewer new diagnoses, the number of those living with HIV surpassed 1 million in 2018 and 1.1 million in 2023.
Why We Still Need A Cure For HIV Despite Powerful Treatments
So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can't rely on them to bring an end to the ongoing global HIV pandemic. Tha ...
UPI16d
FDA approves long-lasting HIV-prevention drug - UPI.com
More than 39,000 people in the United States contracted HIV in 2023, which carries an estimated lifetime treatment cost of $1.1 million per patient, Gilead Chairman and Chief Executive Officer ...